JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M312768200 on May 17, 2004

J. Biol. Chem., Vol. 279, Issue 29, 29895-29901, July 16, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/29/29895    most recent
M312768200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palomba, L.
Right arrow Articles by Cantoni, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palomba, L.
Right arrow Articles by Cantoni, O.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Inhibition of Nitric-oxide Synthase-I (NOS-I)-dependent Nitric Oxide Production by Lipopolysaccharide plus Interferon-{gamma} Is Mediated by Arachidonic Acid

EFFECTS ON NF{kappa}B ACTIVATION AND LATE INDUCIBLE NOS EXPRESSION*

Letizia Palomba{ddagger}§, Tiziana Persichini¶§, Valeria Mazzone¶, Marco Colasanti¶||, and Orazio Cantoni{ddagger}

From the {ddagger}Istituto di Farmacologia e Farmacognosia, Università di Urbino "Carlo Bo," Via S. Chiara 27, 61029 Urbino, Italy and the Dipartimento di Biologia, Università di Roma Tre, Viale Marconi 446, 00146 Roma, Italy

Previous results have indicated that lipopolysaccharide (LPS) plus interferon-{gamma} (IFN{gamma}) inhibits nitric-oxide synthase (NOS)-I activity in glial cells. We report here that arachidonic acid (AA) plays a pivotal role in this response, which was consistently reproduced in different glial cell lines and in primary rat astrocytes. This notion was established using pharmacological inhibitors of phospholipase A2 (PLA2), cytosolic PLA2 (cPLA2) antisense oligonucleotides, and AA add-back experiments. This approach not only allowed the demonstration that AA promotes inhibition of NOS-I activity but also produced novel experimental evidence that LPS/IFN{gamma} itself is a potential stimulus for NOS-I. Indeed, LPS/IFN{gamma} fails to generate nitric oxide (NO) via NOS-I activation simply because it activates the AA-dependent signal that impedes NOS-I activity. Otherwise, LPS/IFN{gamma} promotes NO formation, sensitive to exogenous AA, in cells in which cPLA2 is pharmacologically inhibited or genetically depleted. Because NO suppresses the NF{kappa}B-dependent NOS-II expression, inactivation of NOS-I by the LPS/IFN{gamma}-induced AA pathway provides optimal conditions for NF{kappa}B activation and subsequent NOS-II expression. Inhibition of cPLA2 activity, while reducing the availability of AA, consistently inhibited NF{kappa}B activation and NOS-II mRNA induction and delayed NO formation. These responses were promptly reestablished by addition of exogenous AA. Finally, we have demonstrated that the LPS/IFN{gamma}-dependent tyrosine phosphorylation of NOS-I and inhibition of its activity are mediated by endogenous AA.


Received for publication, November 21, 2003 , and in revised form, May 11, 2004.

* This work was supported by grants from Ministero dell'Università e della Ricerca Scientifica e Tecnologica, Progetti di Ricerca di Interesse Nazionale (to O. C. and M. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Both authors contributed equally to this work.

|| To whom correspondence should be addressed. Tel.: 39-06-55176338; Fax: 39-06-55176321; E-mail: colasant{at}uniroma3.it.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ChestHome page
C. Keen, A.-C. Olin, A. Edentoft, E. Gronowitz, and B. Strandvik
Airway Nitric Oxide in Patients With Cystic Fibrosis Is Associated With Pancreatic Function, Pseudomonas Infection, and Polyunsaturated Fatty Acids
Chest, June 1, 2007; 131(6): 1857 - 1864.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Mizuno and T. Nakamura
Prevention of Neutrophil Extravasation by Hepatocyte Growth Factor Leads to Attenuations of Tubular Apoptosis and Renal Dysfunction in Mouse Ischemic Kidneys
Am. J. Pathol., June 1, 2005; 166(6): 1895 - 1905.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.